SIFROL tablets and Extended-release tablets are indicated for the treatment of the signs and symptoms of idiopathic Parkinson's disease when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose "on off" fluctuations). It may be used alone (without levodopa) or in combination with levodopa.
SIFROL tablets are indicated for the symptomatic treatment of idiopathic Restless Legs Syndrome.